Literature DB >> 7946801

Role of ACE inhibitors in hypertension complicated by vascular disease.

G T McInnes1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7946801      PMCID: PMC1025590          DOI: 10.1136/hrt.72.3_suppl.s33

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


× No keyword cloud information.
  16 in total

Review 1.  Pharmacological approaches to the treatment of intermittent claudication.

Authors:  E G Bevan; P C Waller; L E Ramsay
Journal:  Drugs Aging       Date:  1992 Mar-Apr       Impact factor: 3.923

2.  Treatment of hypertension with captopril: preservation of regional blood flow and reduced platelet aggregation.

Authors:  I M James; E J Dickenson; W Burgoyne; J Y Jeremy; M A Barradas; D P Mikhailidis; P Dandona
Journal:  J Hum Hypertens       Date:  1988-06       Impact factor: 3.012

3.  Effects of captopril on the physical work capacity of normotensive patients with stable-effort angina pectoris.

Authors:  C Strozzi; G Cocco; F Portaluppi; L Urso; R Alfiero; M T Tasini; L Montanari; K Al Yassini; A Rizzo
Journal:  Cardiology       Date:  1987       Impact factor: 1.869

4.  Placebo-controlled comparison of captopril, atenolol, labetalol, and pindolol in hypertension complicated by intermittent claudication.

Authors:  D H Roberts; Y Tsao; G A McLoughlin; A Breckenridge
Journal:  Lancet       Date:  1987-09-19       Impact factor: 79.321

Review 5.  Captopril. An update of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and congestive heart failure.

Authors:  R N Brogden; P A Todd; E M Sorkin
Journal:  Drugs       Date:  1988-11       Impact factor: 9.546

6.  Cerebral blood flow in hypertension.

Authors:  S Strandgaard
Journal:  Acta Med Scand Suppl       Date:  1983

7.  Comparison of enalapril and atenolol in mild to moderate hypertension.

Authors:  A L Herrick; P C Waller; K E Berkin; S D Pringle; J S Callender; M P Robertson; J G Findlay; G D Murray; J L Reid; A R Lorimer
Journal:  Am J Med       Date:  1989-04       Impact factor: 4.965

Review 8.  Angiotensin-converting enzyme inhibitors. Relationship between pharmacodynamics and pharmacokinetics.

Authors:  G G Belz; W Kirch; C H Kleinbloesem
Journal:  Clin Pharmacokinet       Date:  1988-11       Impact factor: 6.447

9.  The variable effects of angiotensin converting enzyme inhibition on myocardial ischaemia in chronic stable angina.

Authors:  J Simon; R Gibbs; P A Crean; L Mockus; C Wright; G C Sutton; K M Fox
Journal:  Br Heart J       Date:  1989-08

10.  Captopril in the treatment of the elderly hypertensive patient.

Authors:  A C Jenkins; J R Knill; G R Dreslinski
Journal:  Arch Intern Med       Date:  1985-11
View more
  1 in total

Review 1.  Angiotensin-converting enzyme inhibitors and coronary artery disease.

Authors:  J W Sayer; A D Timmis
Journal:  Cardiovasc Drugs Ther       Date:  1996-11       Impact factor: 3.727

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.